The Tumor Slayer That Could Reshape the Cancer Drug Market

This little-known biotech may have just cracked the code in chondrosarcoma, a rare cancer with no targeted treatments.

With FDA submission in sight and broad potential across tumor types, is it time to pay close attention?

The difference between “nice returns” and life-changing gains often comes down to timing—and information.

Our latest research has identified 5 stocks positioned for massive growth.

These companies combine strong fundamentals with technical setups that suggest the potential for explosive upside.

Past editions of this same report have included stocks that went on to gain +175%, +498%, even +673%.¹ While the past can’t predict the future, the track record speaks volumes.

For a limited time, you can download the full 5 Stocks Set to Double report—absolutely free.

[Get your free copy before midnight tonight]

Smart investors know: when the window is short, action beats hesitation.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

U.S. stocks surged to record highs as cooler-than-expected inflation data boosted hopes for an October Fed rate cut, while strong earnings from Intel lifted the tech sector.

JPMorgan Chase & Co. (NYSE: JPM) is stepping deeper into the real economy with a big bet on business services.

You might not think of janitorial or HVAC work as dealmaking gold, but JPMorgan’s bankers sure do.

The firm just poached senior executives from Deutsche Bank and Goldman Sachs to lead an expansion into this fast-growing sector.

The goal is to tap into companies that thrive no matter the economic cycle, delivering steady cash flow and acquisition opportunities.

The Next M&A Hotspot

The business services market is booming as more firms outsource non-core work to save money and stay agile.

JPMorgan sees this as fertile ground for mergers, acquisitions, and private equity investments — and you can expect the bank to dominate the middle-market deal space soon.

With plans to quintuple revenue from this segment, the bank’s aggressive hiring spree signals confidence in the resilience of this corner of the economy.

You might even see JPMorgan set a new standard for how Wall Street serves Main Street.

Diversifying the Powerhouse

This move fits into JPMorgan’s broader effort to grow beyond lending and trading into high-margin advisory services.

The focus on recurring, stable sectors gives the bank a fresh stream of predictable earnings in an unpredictable market.

For you, that means the world’s biggest bank is still reinventing itself and doing it by betting on industries that quietly keep business running.

Netflix (NASDAQ: NFLX) had everyone double-checking their screens after a surprise tax charge from Brazil hit last quarter’s earnings.

Shares fell sharply, but the core business, the part that keeps you glued to your couch, remains solid.

Revenue grew steadily, margins held up, and user engagement stayed strong across major regions. For a company juggling multiple international markets, that’s no small feat.

The Global View Gets Bigger

You can see where Netflix is heading by looking past the one-time expense.

The company is expanding fast in Asia and Latin America, two regions where subscriber growth still has miles to run.

Its strategy now blends local content, global licensing, and live entertainment, giving you more ways to stay inside the Netflix world.

And with new ad-supported tiers gaining traction, those extra eyeballs are starting to pay off.

The Long Game Still Streams Strong

For Netflix, this moment feels less like a setback and more like a creative rewrite.

The company is tightening costs, experimenting with live sports, and doubling down on global storytelling that keeps you subscribed month after month.

If you’re waiting for the next hit season in its growth story, don’t log off yet — Netflix’s expansion arc still has plenty of streaming power left.

A single vote in Washington may have just set off crypto’s next bull run.

The GENIUS Act, passed 308–122, is the first true U.S. crypto law — giving the entire industry a green light.

Trump signed it fast, calling America the “crypto capital of the planet.”

That clarity changed everything.

✓ Institutions are pouring in
✓ Banks entering the crypto space
✓ Crypto market surges to $4T

For years, uncertainty held crypto back.

Now, that wall is gone — and the door is wide open.

Get your FREE Crypto Revolution book and discover how to get in early — includes $788 in bonuses.

© 2025 Boardwalk Flock LLC. All Rights Reserved. 2382 Camino Vida Roble, Suite I Carlsbad, CA 92011, United States

The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Readers acknowledge that the authors are not engaging in the rendering of legal, financial, medical, or professional advice. The reader agrees that under no circumstances Boardwalk Flock, LLC is responsible for any losses, direct or indirect, which are incurred as a result of the use of the information contained within this, including, but not limited to, errors, omissions, or inaccuracies.

Results may not be typical and may vary from person to person. Making money trading digital currencies takes time and hard work. There are inherent risks involved with investing, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk.

Target Corporation (NYSE: TGT) is cleaning house with a major corporate shake-up that trims about 1,800 positions at headquarters.

You can think of it as a reboot for a brand that needs more speed and less clutter in how it runs its business.

The move is designed to cut overlap and push decision-making closer to the action.

For you, it signals a shift toward a more data-focused, technology-driven Target that aims to move faster in a retail world that never slows down.

The Spending Slowdown Bites

While inflation continues to ease, shoppers are still watching their wallets.

Target’s reliance on discretionary categories like home goods and apparel has made its recent sales dip sharper than some rivals.

You can already see the effect — fewer impulse buys, slower traffic, and a clear need for a 

learner playbook. By simplifying its structure now, Target hopes to regain balance before another retail storm hits.

A Leaner Path Forward

For Target, this isn’t just a cost-cutting story but a survival strategy.

The company wants to rebuild trust with consumers and investors by proving it can grow efficiently in a tougher spending environment.

If you’re watching retail’s next big turnaround, keep your eyes on how Target blends tech, talent, and timing.

This reset could either spark a comeback or define how the brand competes in 2026 and beyond.

👉 Click here to get our closing report to your cell for free!

Inhibrx Biosciences Inc [INBX] $57.29 (+102.01%)

Inhibrx surged after its targeted therapy ozekibart significantly improved progression-free survival in chondrosarcoma, marking the first major clinical success in this rare cancer.

Genenta Science S.P.A. [GNTA] $6.20 (+91.95%)

Genenta gained after expanding its collaboration with ANEMOCYTE to scale its lentiviral plasmid DNA technology for advanced therapy manufacturing.

MidWestOne Financial Group, Inc [MOFG] $39.54 (+39.37%)

MidWestOne advanced after posting better‑than‑expected quarterly earnings, driven by solid loan growth and improved profitability.

Picard Medical Inc [PMI] $5.58 (-57.68%)

Picard Medical dropped after the company said it was unaware of any undisclosed developments behind recent stock volatility, prompting investor uncertainty.

Deckers Outdoor Corp [DECK] $86.94 (-15.21%)

Deckers plunged after issuing weaker‑than‑expected full‑year sales guidance and warning of softer Ugg demand amid tariff pressures.

Coursera Inc [COUR] $9.19 (-12.94%)

Coursera sank nearly 13% as a weaker‑than‑expected Q4 profitability forecast overshadowed its better‑than‑forecast Q3 revenue and EPS.

Every month, a handful of stocks quietly outperform the rest — and those early movers often go on to deliver double-digit gains.

We’ve identified 7 of them showing the strongest near-term potential based on proprietary screening signals.

These aren’t hype stocks or risky bets.

They’re backed by real earnings power, rising analyst sentiment, and technical strength — the kind of combination that precedes powerful rallies.

See which stocks are poised to lead the market higher over the next 30 days.

Get your free copy of this month’s 7 Market Winners.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.